Real-time enrollment status for this neurotrophic keratopathy clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 12:25 PM UTC
| NCT Number | NCT05555589 |
| Recruiting Status | Recruiting |
| Condition | Neurotrophic Keratopathy |
| Phase | PHASE3 |
| Target Enrollment | 70 participants |
| Active Locations | 29 sites in the US |
| Sponsor | ReGenTree, LLC |
| Last Updated on CT.gov | December 23, 2025 (Dec 23, 2025) |
As of August 27, 2026: Clinical trial NCT05555589 is currently recruiting participants. This phase3 study for neurotrophic keratopathy is actively seeking new participants at 29 locations across the United States. The study is sponsored by ReGenTree, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05555589 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 29 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05555589 was last updated Dec 23, 2025 (December 23, 2025). HelloStudys verifies this status automatically.